President Trump has assented into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. Representative of the Rite Aid Corporation (NYSE:RAD) invited to the White House during the signing in of the bill praised the president for his efforts to quelling the effects of opioid overdose.
Devastating effects of Opioid overdose
The new law was a bipartisan bill drafted by Ohio senators as part of the measures to mitigate Opioid overdose menace. The Ohio Alliance for Innovation in Population Health (OAIPH) conducted a research to establish the effects of Opioid overdose in the seven years the epidemic has stricken Ohio.
The research’s findings were saddening; Ohio had lost over half a million years in life expectancy in under a decade. Through the newly signed bill, pharmacists across the country shall be tasked with providing Medication Therapy Management (MTM) and counseling to at-risk seniors through Medicare Part D.
Speaking about the new law, Jocelyn Konrad Rite Aid Inc.’s Executive Vice President of Pharmacy said that “This law will enable our pharmacists to play a larger role in these efforts by providing Medication Therapy Management (MTM) counseling services to at-risk seniors through Medicare Part D.”
Konrad went ahead to praise all the parties that chipped in drafting the bill singling out a number of Ohio Senators and U.S. Surgeon General Jerome Adams.
Rite Aid commitment in mitigating opioid overdose
Rite Aid has been in the forefront of the war against opioid overdose. The company has been working with government agencies and community awareness groups to combat the epidemic.
Rite Aid has designed a medication, naloxone- that is meant to neutralize the effects of Opioid overdose available across all its pharmacies.
The company also offers DisposeRx packets that are meant for safe disposing off of unused drugs. Besides, Rite aid is deploying one hundred medication Disposal program in its specific pharmacies.
The new law advances Rite Aid pharmacies new tools to continue its righteous fight against the opioid overdoes. Now the company can do more with the government’s backing.
This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.